Read latest articles, updates, and insights on vaccinology
🔬 Tracking breakthrough vaccine development
💔Tuberculosis remains the world's deadliest infectious disease, claiming over 1.2 million lives annually despite being preventable and curable.
🌟For the first time in over a century, multiple promising TB vaccine candidates are in advanced clinical trials, offering hope for millions in high-burden countries.
🎯This dashboard tracks the top 4 vaccine candidates currently in Phase 2 and Phase 3 trials, representing humanity's best chance to end the TB pandemic by 2030.
Total Trials
18
Active worldwide
Phase 3 Trials
6
Final stage
Participants
35,000+
Enrolled globally
Countries
20+
Across continents
This dashboard tracks the top 4 tuberculosis vaccine candidates currently in advanced clinical development. Data is compiled from WHO reports, ClinicalTrials.gov, and sponsor announcements to provide the most accurate picture of TB vaccine progress.
Last updated: November 17, 2025
Sources: WHO Global TB Report 2025, Gates Medical Research Institute, IAVI, Biofabri, Published Research